You are here:
Staff undertaking approved research must follow a strict set of guidelines while conducting their project. All staff involved with the research project must ensure that:
All projects require ongoing research governance site authorisation. The Principle Investigator is responsible for advising the RGO of any amendments to their project/s, as well as submitting annual and final reports, and adverse event reports.
WSLHD HREC advises the WSLHD RGO of all amendments, reports and so on for studies taking place on WSLHD facilities. They do not advise non-WSLHD RGOs: the Principle Investigator will need to advise the appropriate RGO.
For ongoing authorisation to run your project within WSLHD, the Research Governance Ongoing Site Authorisation Form (docx) should be completed by the researcher and signed by the Principal Investigator and forwarded, along with any relevant documents, to the RGO at Westmead Hospital. The ongoing site authorisation form will be acknowledged and returned to the Principal Investigator. If another person requires a copy their details can be added at the end of the form.
Annual reporting is a condition of your ethics approval. One of these forms (on the right) must be submitted annually, in November, to the WSLHD HREC to maintain ongoing HREC approval. If November is not suitable submission date, please liaise with the WSLHD HRE office.
For non-WSLHD HREC approved projects, please contact that Committee's office.
Any amendments or modifications to an approved study must receive approval from the HREC Sub Committee. The process for amendment/modification is outlined in the Amendment Submission Requirements document below.
In the circumstance where a required amendment to the study only involves the addition or removal of a site and or investigator, the following form can be used instead of the full Request for Amendment or Modification Form (above). These requests will be handled out-of-session.
Safety reporting is a condition of your ethics approval and the guidelines set out in the WSLHD Memo SAE & SUSAR Reporting below should be strictly adhered to. Information in relation to monitoring and reporting of safety for clinical trials involving therapeutic goods is also available in the NHMRC document below.
One of the forms below must be submitted to the HREC on completion of the study.
On completion of site involvement in a study, notify the approving HREC and forward any non-WSLHD HREC acknowledgment to the RGO with a completed Research Governance Ongoing Site Authorisation Form (docx). The file will be closed and archived.